$2.37 Billion is the total value of BVF INC/IL's 78 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $228,388,482 | +31.9% | 21,751,284 | 0.0% | 9.64% | +34.8% | ||
| AXSM | New | AXSOME THERAPEUTICS INC | $135,363,150 | – | 1,755,000 | +100.0% | 5.71% | – |
| RPTX | REPARE THERAPEUTICS INC | $121,975,143 | +21.3% | 8,291,988 | 0.0% | 5.15% | +23.9% | |
| KYMR | KYMERA THERAPEUTICS INC | $117,127,396 | +14.7% | 4,692,604 | 0.0% | 4.94% | +17.1% | |
| GHRS | GH RESEARCH PLCordinary shares | $89,690,778 | -16.8% | 9,275,158 | 0.0% | 3.78% | -15.0% | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $89,004,643 | +176.2% | 4,007,413 | 0.0% | 3.76% | +182.2% | |
| CGEM | CULLINAN ONCOLOGY INC | $79,220,572 | -17.7% | 7,509,059 | 0.0% | 3.34% | -15.9% | |
| RVMD | REVOLUTION MEDICINES INC | $77,548,106 | +20.8% | 3,255,588 | 0.0% | 3.27% | +23.4% | |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $66,905,783 | +54.8% | 9,177,748 | +64.2% | 2.82% | +58.2% |
| XOMA | XOMA CORP DEL | $66,451,490 | +2.7% | 3,611,494 | 0.0% | 2.80% | +4.9% | |
| RLAY | Sell | RELAY THERAPEUTICS INC | $57,907,754 | -40.3% | 3,876,021 | -10.7% | 2.44% | -39.1% |
| CTIC | CTI BIOPHARMA CORP | $52,966,256 | +3.3% | 8,813,021 | 0.0% | 2.24% | +5.5% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $51,605,552 | -17.6% | 3,276,543 | -17.6% | 2.18% | -15.8% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $50,125,111 | +54.1% | 1,271,243 | +41.1% | 2.12% | +57.4% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $50,080,018 | -30.7% | 2,736,613 | -25.6% | 2.11% | -29.2% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $47,636,794 | -33.0% | 2,303,520 | -15.2% | 2.01% | -31.5% |
| KURA | Buy | KURA ONCOLOGY INC | $47,170,199 | +7.8% | 3,800,983 | +18.6% | 1.99% | +10.1% |
| New | ZYMEWORKS DEL INC | $46,138,200 | – | 5,870,000 | +100.0% | 1.95% | – | |
| MRUS | Sell | MERUS N V | $46,076,157 | -33.2% | 2,978,420 | -13.5% | 1.94% | -31.8% |
| IMVT | New | IMMUNOVANT INC | $45,457,750 | – | 2,561,000 | +100.0% | 1.92% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $42,370,726 | -66.7% | 1,121,809 | -61.0% | 1.79% | -65.9% |
| ALLK | ALLAKOS INC | $42,158,275 | +37.6% | 5,006,921 | 0.0% | 1.78% | +40.5% | |
| REPL | Buy | REPLIMUNE GROUP INC | $41,415,509 | +158.8% | 1,522,629 | +64.3% | 1.75% | +164.4% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $40,066,467 | -18.5% | 2,205,089 | -33.1% | 1.69% | -16.7% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $36,932,964 | -14.5% | 1,451,197 | -19.3% | 1.56% | -12.7% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $36,190,431 | +1.3% | 1,238,974 | -28.9% | 1.53% | +3.5% |
| ITOS | ITEOS THERAPEUTICS INC | $35,365,608 | +2.5% | 1,810,835 | 0.0% | 1.49% | +4.8% | |
| LXRX | LEXICON PHARMACEUTICALS INC | $30,844,932 | -20.4% | 16,149,179 | 0.0% | 1.30% | -18.7% | |
| GLYC | GLYCOMIMETICS INC | $28,919,114 | +449.2% | 9,544,262 | 0.0% | 1.22% | +459.6% | |
| RAIN | RAIN ONCOLOGY INC | $28,213,832 | +63.9% | 3,526,729 | 0.0% | 1.19% | +67.5% | |
| STRO | Sell | SUTRO BIOPHARMA INC | $27,051,404 | +41.4% | 3,347,946 | -2.9% | 1.14% | +44.6% |
| SLN | SILENCE THERAPEUTICS PLCads | $23,003,344 | +54.5% | 1,508,416 | 0.0% | 0.97% | +57.9% | |
| VIGIL NEUROSCIENCE INC | $22,670,413 | +37.4% | 1,813,633 | 0.0% | 0.96% | +40.3% | ||
| EPIX | ESSA PHARMA INC | $22,046,545 | +38.5% | 8,748,629 | 0.0% | 0.93% | +41.3% | |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $21,372,470 | -22.9% | 6,894,345 | 0.0% | 0.90% | -21.2% | |
| CNCE | CONCERT PHARMACEUTICALS INC | $21,193,360 | -12.8% | 3,629,000 | 0.0% | 0.89% | -11.0% | |
| ANNX | ANNEXON INC | $19,546,188 | -16.3% | 3,780,694 | 0.0% | 0.82% | -14.5% | |
| JANX | JANUX THERAPEUTICS INC | $19,364,299 | -2.7% | 1,470,334 | 0.0% | 0.82% | -0.6% | |
| TYRA BIOSCIENCES INC | $18,789,685 | -13.5% | 2,472,327 | 0.0% | 0.79% | -11.7% | ||
| Buy | THIRD HARMONIC BIO INC | $18,773,512 | -71.7% | 4,365,933 | +24.7% | 0.79% | -71.1% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $18,648,182 | -11.2% | 7,611,503 | 0.0% | 0.79% | -9.3% | |
| New | NEWAMSTERDAM PHARMA COMPANYordinary shares | $16,010,893 | – | 1,521,948 | +100.0% | 0.68% | – | |
| ACIU | AC IMMUNE SA | $15,153,893 | -35.4% | 7,428,379 | 0.0% | 0.64% | -34.0% | |
| Sell | AN2 THERAPEUTICS INC | $14,904,567 | -47.0% | 1,563,963 | -3.3% | 0.63% | -45.8% | |
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $13,147,500 | +16.1% | 750,000 | 0.0% | 0.56% | +18.6% | |
| OVID | OVID THERAPEUTICS INC | $12,742,955 | +1.1% | 6,851,051 | 0.0% | 0.54% | +3.3% | |
| VERV | VERVE THERAPEUTICS INC | $12,577,500 | -43.7% | 650,000 | 0.0% | 0.53% | -42.4% | |
| COGT | Sell | COGENT BIOSCIENCES INC | $11,384,565 | -63.4% | 984,824 | -52.8% | 0.48% | -62.6% |
| CTMX | CYTOMX THERAPEUTICS INC | $10,553,282 | +10.3% | 6,595,801 | 0.0% | 0.44% | +12.7% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $8,349,159 | +2.1% | 1,135,940 | 0.0% | 0.35% | +4.1% | |
| VSTM | Sell | VERASTEM INC | $7,656,619 | -54.9% | 19,022,656 | -4.8% | 0.32% | -53.9% |
| NLSP | New | NLS PHARMACEUTICS LTD | $7,413,793 | – | 5,747,126 | +100.0% | 0.31% | – |
| Sell | AADI BIOSCIENCE INC | $7,214,424 | -41.9% | 562,309 | -36.0% | 0.30% | -40.7% | |
| IKNA | IKENA ONCOLOGY INC | $6,658,169 | -25.1% | 2,503,071 | 0.0% | 0.28% | -23.4% | |
| ARAV | New | ARAVIVE INC | $6,315,162 | – | 4,784,214 | +100.0% | 0.27% | – |
| ELDN | ELEDON PHARMACEUTICALS INC | $5,397,967 | -15.9% | 2,326,710 | 0.0% | 0.23% | -14.0% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $5,283,533 | -9.6% | 5,080,320 | 0.0% | 0.22% | -7.5% | |
| VIRX | VIRACTA THERAPEUTICS INC | $5,277,407 | -65.8% | 3,614,662 | 0.0% | 0.22% | -65.0% | |
| CDTX | CIDARA THERAPEUTICS INC | $5,189,070 | +20.4% | 6,861,127 | 0.0% | 0.22% | +23.0% | |
| GLPG | New | GALAPAGOS NVspon adr | $4,438,000 | – | 100,000 | +100.0% | 0.19% | – |
| Sell | HILLEVAX INC | $4,158,727 | -36.4% | 248,579 | -35.0% | 0.18% | -34.8% | |
| PYXIS ONCOLOGY INC | $3,938,060 | -32.0% | 2,938,851 | 0.0% | 0.17% | -30.5% | ||
| INFI | INFINITY PHARMACEUTICALS INC | $3,526,273 | -53.4% | 6,353,645 | 0.0% | 0.15% | -52.2% | |
| IVA | INVENTIVA SAads | $3,039,157 | +14.5% | 686,040 | 0.0% | 0.13% | +16.4% | |
| MOLN | MOLECULAR PARTNERS AGads | $2,872,072 | -3.3% | 443,221 | 0.0% | 0.12% | -1.6% | |
| ELEV | ELEVATION ONCOLOGY INC | $2,191,272 | -16.1% | 2,312,200 | 0.0% | 0.09% | -14.8% | |
| MTEM | MOLECULAR TEMPLATES INC | $1,638,873 | -56.3% | 4,996,565 | 0.0% | 0.07% | -55.5% | |
| IMUX | New | IMMUNIC INC | $1,609,195 | – | 1,149,425 | +100.0% | 0.07% | – |
| SELB | SELECTA BIOSCIENCES INC | $1,572,676 | -31.1% | 1,391,749 | 0.0% | 0.07% | -29.8% | |
| CALITHERA BIOSCIENCES INC | $1,515,059 | +10.9% | 464,742 | 0.0% | 0.06% | +14.3% | ||
| XFOR | Buy | X4 PHARMACEUTICALS INC | $1,338,216 | -7.7% | 1,347,650 | +58.9% | 0.06% | -6.7% |
| CRVS | CORVUS PHARMACEUTICALS INC | $1,165,305 | +3.9% | 1,370,947 | 0.0% | 0.05% | +6.5% | |
| GLMD | Sell | GALMED PHARMACEUTICALS LTD | $869,835 | +55.9% | 1,739,670 | -3.3% | 0.04% | +60.9% |
| ANGN | ANGION BIOMEDICA CORP | $869,465 | -11.8% | 1,071,297 | 0.0% | 0.04% | -9.8% | |
| New | AILERON THERAPEUTICS INC | $561,299 | – | 236,835 | +100.0% | 0.02% | – | |
| GBIO | Sell | GENERATION BIO CO | $404,397 | -78.9% | 102,900 | -71.6% | 0.02% | -78.5% |
| RZLT | REZOLUTE INC | $394,987 | -24.5% | 190,815 | 0.0% | 0.02% | -22.7% | |
| BIONOMICS LIMITEDads | $373,276 | -35.4% | 80,971 | 0.0% | 0.02% | -33.3% | ||
| CFRX | Exit | CONTRAFECT CORP | $0 | – | -472,300 | -100.0% | -0.00% | – |
| ERYP | Exit | ERYTECH PHARMAsponsored adr | $0 | – | -1,314,656 | -100.0% | -0.03% | – |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -5,265,555 | -100.0% | -0.04% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -3,532,057 | -100.0% | -0.06% | – |
| FWP | Exit | FORWARD PHARMA A/Ssponsord ads new | $0 | – | -513,791 | -100.0% | -0.06% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -1,929,376 | -100.0% | -0.16% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -3,143,682 | -100.0% | -0.75% | – |
| Exit | EQRX INC | $0 | – | -6,008,187 | -100.0% | -1.23% | – | |
| Exit | NUVALENT INC | $0 | – | -1,666,282 | -100.0% | -1.34% | – | |
| Exit | CINCOR PHARMA INC | $0 | – | -1,312,443 | -100.0% | -1.78% | – | |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -2,078,220 | -100.0% | -3.18% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.